Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioma × terameprocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Oligodendroglioma 1 Neoplasms 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 77 Bevacizumab 45 Radiotherapy 30 Irinotecan 19 Carboplatin 17 Magnetic Resonance Spectroscopy 16 Surgical Procedures, Operative 13 Carmustine 13 Radiation 9 Nivolumab 8 Erlotinib Hydrochloride 8 Thalidomide 7 Lomustine 7 Imatinib Mesylate 7 IL13-PE38 7 Everolimus 7 Aminolevulinic Acid 7 sargramostim 6 Topotecan 6 Radiotherapy, Intensity-Modulated 6 Cyclophosphamide 6 Chemotherapy, Adjuvant 6 vandetanib 5 fluorodopa F 18 5 Vincristine 5 Surveys and Questionnaires 5 Radiosurgery 5 Filgrastim 5 Blood Specimen Collection 5 temsirolimus 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02575794 2023-10-06

Terameprocol in Treating Patients With Recurrent High Grade Glioma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡